Updated clinical practice guidelines for the management of biliary tract cancers: Revision concepts and major revised points

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 22, Issue 4, 2015, Pages 274-278

  Yoshitomi, Hideyuki ^a   Miyakawa, Shuichi ^b   Nagino, Masato ^c   Takada, Tadahiro ^d   Miyazaki, Masaru ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Toyota Regional Medical Center   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ampullary carcinoma; Bile duct carcinoma; Biliary tract cancer; Clinical guidelines; Gallbladder carcinoma

Indexed keywords

CISPLATIN; GEMCITABINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR;

ARTICLE; BILE DUCT CANCER; BILIARY TRACT CANCER; BILIARY TRACT DRAINAGE; BILIARY TRACT SURGERY; CONTRAST ENHANCEMENT; COST BENEFIT ANALYSIS; ENDOSCOPIC SURGERY; GALLBLADDER CARCINOMA; HISTOLOGY; HUMAN; INTRAOPERATIVE PERIOD; JAPANESE (PEOPLE); MEDICAL SOCIETY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRACTICE GUIDELINE; PRECANCER; RISK BENEFIT ANALYSIS; SURGICAL APPROACH; BILIARY TRACT NEOPLASMS; DISEASE MANAGEMENT; REOPERATION; STANDARDS;

BILIARY TRACT NEOPLASMS; BILIARY TRACT SURGICAL PROCEDURES; DISEASE MANAGEMENT; HUMANS; PRACTICE GUIDELINES AS TOPIC; REOPERATION;

EID: 84925970892     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1002/jhbp.234     Document Type: Article

References (34)

1. Takada T,. Clinical practice guidelines for the management of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008; 15: 1.
2. Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Kondo S, et al. Purpose, use, and preparation of clinical practice guidelines for the management of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008; 15: 2-6.
3. Miyazaki S, Ishihara S, Takada T, Miyazaki M, Tsukada K, Nagino M, et al. Flowcharts for the management of biliary tract and ampullary carcinoma. J Hepatobiliary Pancreat Surg. 2008; 15: 7-14.
4. Miyazaki M, Takada T, Miyakawa S, Tsukada K, Nagino M, Kondo S, et al. Risk factors for biliary tract and ampullary carcinomas and prophylactic surgery for these factors. J Hepatobiliary Pancreat Surg. 2008; 15: 15-24.
5. Nagino M, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Kondo S, et al. Preoperative biliary drainage for biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008; 15: 25-30.
6. Tsukada K, Takada T, Miyazaki M, Miyakawa S, Nagino M, Kondo S, et al. Diagnosis of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008; 15: 31-40.
7. Kondo S, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, et al. Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepatobiliary Pancreat Surg. 2008; 15: 41-54.
8. Furuse J, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, et al. Guidelines for chemotherapy of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008; 15: 55-62.
9. Saito H, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, et al. Radiation therapy and photodynamic therapy for biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008; 15: 63-68.
10. Tsuyuguchi T, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, et al. Stenting and interventional radiology for obstructive jaundice in patients with unresectable biliary tract carcinomas. J Hepatobiliary Pancreat Surg. 2008; 15: 69-73.
11. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations BMJ. 2004; 328: 1490-1494.
12. Unnno M, Okumoto T, Katayose Y, Rikiyama T, Sato A, Motoi F, et al. Preoperative assessment of hilar cholangiocarcinoma by multidetector row computed tomography. J Hepatobiliary Pancreat Surg. 2007; 14: 434-440.
13. Endo I, Shimada H, Sugita M,. Role of three-dimensional imaging in operative planning for hilar cholangiocarcinoma. Surgery. 2007; 142: 666-675.
14. Chen HW, Lai EC, Pan AZ, Chen T, Liao S, Lau WY,. Preoperative assessment and staging of hilar cholangiocarcinoma with 16-multidetector computed tomography chorangiography and angiography. Hepatogastroenterology. 2009; 56: 578-583.
15. Kumaran V, Gulati S, Paul B, Pande K, Sahni P, Chattopandhyay K,. The role of dual-phase helical CT in assessing resectability of carcinoma of the gallbladder. Eur Radiol. 2002; 12: 1993-1999.
16. Kalra N, Suri S, Gupta R, Natarajan SK, Khandelwal N, Wig JD, et al. MDCT in the staging of gallbladder carcinoma. AJR Am J Roentgenol. 2006; 186: 758-762
17. Kim SJ, Lee JM, Lee JY, Choi JY, Kim SH, Han JL, et al. Accuracy of preoperative T-staging of gallbladder carcinoma using MDCT. AJR Am J Roentgenol. 2008; 190: 74-80.
18. Kawakami H, Kuwatani M, Onodera M, Haba S, Eto K, Ehira N, et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma. J Gastroetrerol. 2011; 46: 242-248.
19. Takahashi Y, Nagino M, Nishio H, Ebata T, Igami T, Nimura Y,. Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma. Br J Surg. 2010; 97: 1860-1866.
20. Hirano S, Tanaka E, Tsuchikawa T, Matsumoto J, Kawakami H, Nakamura T, et al. Oncological benefits of preoperative endoscopic drainage in patients with hilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2014; 21: 533-540.
21. Igami T, Nagino M, Oda K, Nishio H, Ebata T, Yokoyama Y, et al. Clinicopathologic study of cholangiocarcinoma with superficial spread. Ann Surg. 2009; 249: 296-302.
22. Wakai T, Shirai Y, Moroda T, Yokoyama N, Hatakeyama K,. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer. 2005; 103: 1210-1216.
23. Sasaki R, Takeda Y, Funato O, Nitta H, Kawamura H, Uesugi N, et al. Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma. World J Surg. 2007; 31: 1788-1796.
24. Ojima H, Kanai Y, Iwasaki M, Hiraoka N, Shimada K, Sano T, et al. Intraductal carcinoma component as a favorable prognostic factor in biliary tract carcinoma. Cancer Sci. 2009; 100: 62-70.
25. Nakanishi Y, Kondo S, Zen Y, Yonemori A, Kubota K, Kawakami H, et al. Impact of residual in situ carcinoma on postoperative survival in 125 patients with extrahepatic bile duct carcinoma. J Hepatobiliary Pancreat Sci. 2010; 17: 166-173.
26. Higuchi R, Ota T, Araida T, Kobayashi M, Furukawa T, Yamamoto M,. Prognostic relevance of ductal margins in operative resection of bile duct cancer. Surgery. 2010; 148: 7-14.
27. Araida T, Higuchi R, Hamano M, Kodera Y, Takeshita N, Ota T, et al. Should the extrahepatic bile duct be resected or preserved in R0 radical surgery for advanced gallbladder carcinoma? Results of a Japanese Society of Biliary Surgery Survey: a multicenter study. Surg Today. 2009; 39: 770-779.
28. Tsukada K, Hatakeyama K, Kurosaki I, Uchida K, Shirai Y, Muto T, et al. Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery. 1996; 120: 816-21.
29. Shimizu Y, Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, et al. Should the extrahepatic bile duct be resected for locally advanced gallbladder cancer? Surgery. 2004; 136: 1012-7.
30. Kokudo N, Makuuchi M, Natori T, Sakamoto Y, Yamamoto J, Seki M, et al. Strategies for surgical treatment of gallbladder carcinoma based on information available before resection. Arch Surg. 2003; 138: 741-50.
31. Sakamoto Y, Kosuge T, Shimada K, Sano T, Hibi T, Yamamoto J, et al. Clinical significance of extrahepatic bile duct resection for advanced gallbladder cancer. J Surg Oncol. 2006; 94: 298-306.
32. Suzuki S, Yokoi Y, Kurachi K, Inaba K, Ota S, Azuma M, et al. Appraisal of surgical treatment for pT2 gallbladder carcinomas. World J Surg. 2004; 28: 160-5.
33. Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010; 362: 1273-1281.
34. Okusaka T, Nakachi K, Fukutomi A, Mizuno N, Ohkawa S, Funakoshi A, et al. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer. 2010; 103: 469-474.